Malignant hyperthermia: a case report with good outcome
Tiago F.G. Barbosa,Andreia Machado,Inês A. Correia,Ana C. Sá
DOI: https://doi.org/10.1097/j.pbj.0000000000000080
2021-01-01
Porto Biomedical Journal
Abstract:To the EditorWe present a case report of a 63-year-old man with ocular trauma admitted to the operating room for vitrectomy. He had medical history of hypertension, dyslipidemia, alcohol abuse, and chronic obstructive pulmonary disease Gold IIIC. He had been submitted to gastric suture under general anesthesia, 30 years ago with no known complications. He denied familial history of anesthetic complications. Pulmonary wheezing and rumbles were evident at auscultation. Standard American Society of Anesthesiologists monitorization was ensured and <em>rapid sequence induction</em> with propofol, fentanyl, and rocuronium was achieved. Sevoflurane was used for maintenance. Ninety minutes after induction, EtCO<sub>2</sub> started to rise (60 mm Hg) with an obstructive capnography curve, increased airway pressure, and worsening of pulmonary wheezing at auscultation. Bronchospasm was assumed and treated with salbutamol, ipratropium bromide, hydrocortisone, magnesium sulfate, and ketamine. Despite treatment and ventilation adjustment, EtCO<sub>2</sub> continued to rise until a maximum of 100 mm Hg. An arterial blood gas (ABG) analysis was obtained, showing acidosis (pH = 7.16) with hypercapnia (pCO<sub>2</sub> = 88.7 mm Hg) and desaturation (SatO<sub>2</sub> = 93.9%, with FiO<sub>2</sub> = 60%, and pO<sub>2</sub> = 88.6 mm Hg). Muscular rigidity became evident and temperature increased to a maximum of 40.5°C. The diagnosis of malignant hyperthermia was assumed. Sevoflurane was discontinued. High flow ventilation (FiO<sub>2</sub> 100%) and propofol perfusion were initiated. A dantrolene intravenous (iv) bolus (2.5 mg/kg) and 100 mL of 8.4% sodium bicarbonate were administered and active cooling measures initiated. An arterial line, central venous catheter, and urinary catheter were promptly placed. Venous blood samples were obtained to evaluate muscular enzymes, hepatic, and renal function. Intravenous crystalloids and 1 mg/kg furosemide were administered to maintain urine output and prevent renal injury. Noradrenaline infusion was started to maintain adequate median arterial pressures. ABG after starting therapeutic measures showed significant respiratory acidosis with severe hypercapnia (pH = 7.0, pCO<sub>2</sub> = 156.9 mm Hg), without hypoxemia (PaO<sub>2</sub> = 380 mm Hg with FiO<sub>2</sub> = 100%), and a mild increase in lactate (2.7 mmol/L). Another iv bolus of dantrolene was given (total dose of 5 mg/kg). After a few minutes, temperature and EtCO<sub>2</sub> started to drop. Forty-five minutes later, patient stabilized registering a core temperature of 37.2°C. Serialized ABG showed a progressive improvement in acidosis (pH = 7.355, pCO<sub>2</sub> = 67.9 mm Hg). After stabilizing, he was taken to the intensive care unit (ICU) sedated with propofol and fentanyl, intubated and with a 24-hour iv infusion of dantrolene (0.25 mg/kg/h). In the ICU, muscular and hepatic enzymes gradually normalized, and renal function remained preserved. Patient was extubated on the third day, discharged from ICU on the fourth day and from the hospital 12 days after the procedure. Patient was referenced to follow-up anesthesiology and genetic consultations, where in vitro caffeine-halothane contracture and DNA tests confirmed the diagnosis of malignant hyperthermia (MH).